India's Pharmaceutical Exports

Country Profile

Indonesia

Indonesia is a significant market for Indian pharmaceutical exports — $256M in FY 2025–26, with 4.0× growth over the past decade. Medicine Ingredients accounts for 42% of shipments, with vaccines contributing $93.8M. The compound annual growth rate since FY2015 stands at 13.5%.

🇮🇩 $256M · 4.0× growth since FY2015 · 13.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$256M
Exports FY2025–26 DGCIS
4.0×
Growth FY2015→2026
13.5%
CAGR FY2015→2026
42%
Medicine Ingredients Share
5
Product Categories Supplied
Indonesia is a significant market for Indian pharmaceutical exports — $256M in FY 2025–26, with 4.0× growth over the past decade. Medicine Ingredients accounts for 42% of shipments, with vaccines contributing $93.8M. The compound annual growth rate since FY2015 stands at 13.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $108M (42.3%) Vaccines $93.8M (36.7%) Medicines $41.4M (16.2%) Surgical & Hospital Supplies $9.45M (3.7%) Traditional & Herbal $2.83M (1.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Indonesia in the RBI overseas direct investment dataset (2011–2026).